ACRIVON THERAPEUTICS INC (ACRV) Earnings History & Surprises

NASDAQ:ACRV • US0048901096

Current stock price

1.85 USD
+0.04 (+2.21%)
At close:
1.81 USD
-0.04 (-2.16%)
Pre-Market:

ACRV Earnings overview

Past quarterly earnings results for ACRIVON THERAPEUTICS INC (ACRV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
282.203K

Last Reported

Most Recent
Release Date
Mar 19, 2026
Period
Q4 / 2025
EPS Reported
-$0.52
EPS Surprise
-9.34%
Revenue Surprise
-100.00%

Beat Rate

Last 8 Quarters
38%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.52 -0.48 -9.34% 13.33% 169.024K -100.00% -
Q3 2025 -0.47 -0.60 21.90% 20.34% - -
Q2 2025 -0.55 -0.60 8.02% -5.77% - -
Q1 2025 -0.51 -0.66 22.15% 30.14% - -
Q4 2024 -0.60 -0.68 11.91% 30.23% - -
Q3 2024 -0.59 -0.59 -0.13% 10.61% - -
Q2 2024 -0.52 -0.61 15.33% 17.46% - -
Q1 2024 -0.73 -0.86 15.28% -25.86% - -
Q4 2023 -0.86 -0.74 -15.99% -7.50% - -
Q3 2023 -0.66 -0.72 8.67% - - -
Q2 2023 -0.63 -0.66 4.77% - - -
Q1 2023 -0.58 -0.61 5.27% - - -
Q4 2022 -0.80 -1.12 28.37% - - -
Q3 2022 - - - -
Q2 2022 - - - -
Q4 2021 - - - -
Q2 2021 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ACRV EPS Q2Q GrowthACRV EPS Q2Q GrowthEPS Q2Q Growth Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 Q1/27 Q2/27 Q3/27 Q4/27 0 10 -10 20 -20 30

Revenue Historical Q2Q growth and Acceleration

ACRV Revenue Q2Q GrowthACRV Revenue Q2Q GrowthRevenue Q2Q Growth Q1/27 Q2/27 Q3/27 Q4/27 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
10.68%
Max EPS beat (4)
22.15%
Min EPS beat (4)
-9.34%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, ACRV has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, ACRV has beaten the EPS estimates by 10.7% on average.
ACRV Overview ACRV Technical Analysis Report ACRV Fundamental Analysis Report ACRV Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ACRIVON THERAPEUTICS INC / ACRV Earnings FAQ

Can you provide the last earnings date for ACRIVON THERAPEUTICS INC?

ACRIVON THERAPEUTICS INC (ACRV) last reported earnings on 3/19/2026.

Did ACRIVON THERAPEUTICS INC (ACRV) beat earnings estimates last quarter?

ACRIVON THERAPEUTICS INC (ACRV) missed EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does ACRV stock beat earnings estimates?

In the last 4 quarters, ACRIVON THERAPEUTICS INC (ACRV) has beaten EPS estimates in 3 out of 4 releases.